Filing Flows › China Pharma Holdings (CPHI) › Q2 2026 › vs Q2 2025
China Pharma Holdings (CPHI) Q2 2026 vs Q2 2025 (year over year)
China Pharma Holdings's revenue fell $77K (-8%) from $1.0M in Q2 2025 to $948K in Q2 2026.
China Pharma Holdings, Q2 2026: revenue $948K (-8% year over year), operating margin -151.0%, net loss $1.5M, operating cash flow −$33K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $948K | $1.0M | −$77K | -8% |
| Net loss | $1.5M | $528K | $930K | +176% |
| Costs & expenses | $2.4M | $1.7M | $729K | +43% |
| Operating costs | $2.4M | $1.7M | $702K | +42% |
| Interest & other, net | $26K | −$124K | $150K | — |
| Cost of revenue | $865K | $1.1M | −$248K | -22% |
| Research & development | $19K | $21K | −$2K | -9% |
| Sales & marketing | $114K | $101K | $12K | +12% |
| General & admin | $1.4M | $441K | $936K | +212% |
| Operating cash sources | $1.5M | $528K | $930K | +176% |
| Depreciation & amortization | $1.1M | $321K | $781K | +243% |
| Working capital & other | $323K | $482K | −$158K | -33% |
| Cash used in operations | $33K | −$274K | $307K | — |
| Net loss absorbed | $1.5M | $528K | $930K | +176% |
Questions
How much did China Pharma Holdings's revenue grow year over year in Q2 2026?
China Pharma Holdings's revenue fell $77K (-8%) from $1.0M in Q2 2025 to $948K in Q2 2026.